Latest Manufacturing News

Page 9 of 335
Cadoux Limited (ASX:CCM) has strengthened the technical case for its high-purity alumina and rare earths portfolio, including battery qualification and new Danube mineralisation beyond its previous exploration envelope. The progress comes with a thinner cash buffer, no listed financing facilities and several commercial milestones still ahead.
Victor Sage
Victor Sage
30 Oct 2026
Kore Potash says it is still negotiating how the Republic of Congo’s new Mining Law will apply to the Kola Mining Convention, with construction required to begin by 8 June 2027. Two parties remain in the Formal Sale Process, while Kola’s environmental assessment is paused and the company held approximately US$6.4 million in cash at quarter-end.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Alpha HPA has moved closer to commissioning its flagship Stage 2 facility, with permanent plant energisation targeted for December while Stage 1 customer demand continues to outstrip available capacity. The company also began drawing funds from a $160 million government-backed commitment and reported $81.4 million in cash at quarter-end.
Victor Sage
Victor Sage
30 Oct 2026
CONNEQT Health ended the September quarter with just A$501,000 in cash after a A$3.06 million operating outflow, equivalent to 0.16 quarters of funding at the reported burn rate. The company is pursuing R&D-backed debt, inventory finance and an equity raising as Pulse sales recover from an inventory disruption.
Victor Sage
Victor Sage
30 Oct 2026
LGP Cannatrek generated A$4.4 million in net operating cash flow on unaudited quarterly revenue of A$26.0 million, providing the first clean look at the merged group’s operations. Cost synergies, Danish production upgrades and UK expansion are advancing, while a pending TGA penalty remains an unresolved risk.
Ada Torres
Ada Torres
30 Oct 2026
Proteomics International has begun the national rollout of its Promarker D and Promarker Eso blood tests through Healius, while a A$2 million tax incentive receipt has lifted pro forma cash to A$3.8 million. Promarker Endo also cleared an independent Oxford validation hurdle, but its commercial launch remains conditional.
Ada Torres
Ada Torres
30 Oct 2026
EZZ Life Science cut its quarterly operating cash outflow sharply despite a 37.7% drop in customer receipts, as weaker Chinese e-commerce sales continued to weigh. EAORON skincare growth and a $9.16 million cash balance offer some support, but distributor collections and potential product returns remain unresolved.
Victor Sage
Victor Sage
30 Oct 2026
Strategic Elements has moved its EdgeiQ platform closer to commercial mining pilots while Energy Ink progresses towards a system-level demonstration. The ASX-listed venture developer ended September with $3.918 million in cash and an estimated 4.32 quarters of funding at the quarter’s spending rate.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Complii FinTech Solutions ended September with $168,000 in cash after a $1.20 million operating cash outflow, leaving just 0.14 quarters of funding at the reported burn rate. Management points to cost reductions, stronger revenue and a $1.24 million R&D rebate received in October as the route to improved liquidity.
Victor Sage
Victor Sage
30 Oct 2026
Xenitra has returned to positive quarterly gross profit as its new pharmaceutical and Web3 businesses begin generating revenue, but statutory operating cash flow remained negative at A$790,000. The company is now relying on procurement targets, repeat Web3 sales and further capital discipline to turn early commercial activity into sustainable cash generation.
Victor Sage
Victor Sage
30 Oct 2026
Radiopharm Theranostics is preparing to start a pivotal RAD101 brain-metastases imaging trial in early 2027 after a successful FDA meeting. The clinical progress comes with a sharper funding question: the company reported A$7.46 million in cash against A$10.69 million of quarterly operating outflows, before a subsequent A$8 million tax-incentive-backed advance.
Ada Torres
Ada Torres
30 Oct 2026
ClearVue Technologies has converted its Canva project into a binding subcontract and secured certifications that broaden the market for its solar glass. But the ASX-listed company ended Q1 FY27 with A$2.281 million in cash, A$2.666 million of quarterly operating outflows and estimated funding for just 1.3 quarters.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive